Exact Mass: 337.0466036

Exact Mass Matches: 337.0466036

Found 226 metabolites which its exact mass value is equals to given mass value 337.0466036, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

5-Hydroxymethyldeoxycytidylate

5-Hydroxymethyldeoxycytidylate; 5-Hydroxymethyldeoxycytidylic acid; 2-Deoxy-5-hydroxymethylcytidine 5-phosphate

C10H16N3O8P (337.0674986)


   
   

S-Hydroxymethylglutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoic acid

C11H19N3O7S (337.0943664)


S-Hydroxymethylglutathione is a critical component of the binding site for activating fatty acids in glutathione-dependent formaldehyde dehydrogenase activity (OMIM: 103710). Formaldehyde dehydrogenase (FDH; EC 1.2.1.1), a widely occurring enzyme, catalyzes the oxidation of S-hydroxymethylglutathione into S-formylglutathione in the presence of NAD (PMID: 2806555). S-Hydroxymethylglutathione is a critical component of the binding site for activating fatty acids in glutathione-dependent formaldehyde dehydrogenase activity. (OMIM 103710)

   

tenoxicam

tenoxicam

C13H11N3O4S2 (337.0190966)


M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

famotidine

Famotidine (Pepcid)

C8H15N7O2S3 (337.044933)


A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

   

Famotidine

3-[({2-[(diaminomethylidene)amino]-1,3-thiazol-4-yl}methyl)sulfanyl]-N-sulfamoylpropanimidamide

C8H15N7O2S3 (337.044933)


Famotidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD). It is commonly marketed by Merck under the trade names Pepcidine and Pepcid. [HMDB] Famotidine is a histamine H2-receptor antagonist that inhibits stomach acid production, and is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD). It is commonly marketed by Merck under the trade names Pepcidine and Pepcid. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

   

Tenoxicam

(3Z)-3-{hydroxy[(pyridin-2-yl)amino]methylidene}-2-methyl-2H,3H,4H-1λ⁶-thieno[2,3-e][1,2]thiazine-1,1,4-trione

C13H11N3O4S2 (337.0190966)


Tenoxicam is only found in individuals that have used or taken this drug. It is an antiinflammatory agent with analgesic and antipyretic properties, and is used to treat osteoarthritis and control acute pain.The antiinflammatory effects of tenoxicam may result from the inhibition of the enzyme cycooxygenase and the subsequent peripheral inhibition of prostaglandin synthesis. As prostaglandins sensitize pain receptors, their inhibition accounts for the peripheral analgesic effects of tenoxicam. Antipyresis may occur by central action on the hypothalamus, resulting in peripheral dilation, increased cutaneous blood flow, and subsequent heat loss. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AC - Oxicams D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D004791 - Enzyme Inhibitors

   

gamma-Glutamylcysteinylserine

2-Amino-4-({1-[(1-carboxy-2-hydroxyethyl)-C-hydroxycarbonimidoyl]-2-sulphanylethyl}-C-hydroxycarbonimidoyl)butanoic acid

C11H19N3O7S (337.0943664)


gamma-Glutamylcysteinylserine is found in cereals and cereal products. gamma-Glutamylcysteinylserine is a constituent of many grasses including Triticum aestivum (wheat). Constituent of many grasses including Triticum aestivum (wheat). gamma-Glutamylcysteinylserine is found in wheat and cereals and cereal products.

   

2,8-Dihydroxyquinoline-beta-D-glucuronide

(2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[(8-hydroxyquinolin-2-yl)oxy]oxane-2-carboxylic acid

C15H15NO8 (337.079763)


2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978) [HMDB] 2,8-Dihydroxyquinoline-beta-D-glucuronide is a glucuronide conjugate of 2,8-Dihydroxyquinoline. 2,8-Dihydroxyquinoline is an intermediate in gut microbial metabolism of quinoline or 8-hydroxyquinoline. Quinoline is also used as a catalyst, a corrosion inhibitor, in metallurgical processes, in the manufacture of dyes, as a preservative for anatomical specimens, in polymers and agricultural chemicals, and as a solvent for resins and terpenes. It is also used as an antimalarial medicine. 2,8-Dihydroxyquinoline-beta-D-glucuronide has been identified as a potential urinary biomarker that is elevated by peroxisome proliferator-activated receptor (PPARalpha) agonists. (PMID: 17550978).

   

3-Indole carboxylic acid glucuronide

(3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1H-indole-3-carbonyloxy)oxane-2-carboxylic acid

C15H15NO8 (337.079763)


3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. [HMDB] 3-Indole carboxylic acid glucuronide is a natural human metabolites of Indole-3-carboxylic acid. Indole-3-carboxylic acid is a normal urinary indolic tryptophan metabolite (PMID 4844607) and has been found elevated in patients with liver diseases (PMID 13905029). Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys.

   

2-Oxoclopidogrel

(2S)Methyl 2-(2-chlorophenyl)-2-(2-oxo-7,7a-dihydrothieno(3,2-c)pyridin-5(2H,4H,6H)-yl)acetate

C16H16ClNO3S (337.05393760000004)


2-Oxoclopidogrel is a thiolactone intermediate of clopidogrel, an antithrombotic prodrug (PMID: 23249383).. Hepatic cytochrome P450 (P450) enzymes catalyze the conversion of clopidogrel to 2-oxo-clopidogrel via CYP3A oxidation. After oxidation, 2-oxoclopidogrel is then subsequently hydrolyzed to the clopidogrel active metabolite known as CAM (PMID: 25970225). 2-oxoclopidogrel can form four isomers (H1, H2, H3 and H4) of CAM, in which H4 only found in humans. The H4 isomer exhibits twice the activity of the H2 isomer (PMID: 28602635). The H4 isomer blocks adenosine diphosphate (ADP) binding to the P2Y12 receptor which thereby inhibits ADP induced platelet aggregation. 2-oxoclopidogrel is only found in individuals that have used or taken Clopidogrel. Clopidogrel thiolactone is an important intermediate in the metabolism of clopidogrel (HY-15283). Clopidogrel thiolactone has antiplatelet aggregatione effects. Clopidogrel is a P2Y12 receptor inhibitor that exerts antiplatelet effects[1][2].

   

5-Carboxy-lumiracoxib

3-{[2-(carboxymethyl)-4-methylphenyl]amino}-4-chloro-2-fluorobenzoic acid

C16H13ClFNO4 (337.05171000000007)


5-Carboxy-lumiracoxib is a metabolite of lumiracoxib. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as Prestige by the media). Lumiracoxib has several distinctive features. (Wikipedia)

   

1H-Imidazole-1-ethanol, 2-nitro-alpha-((2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)methyl)-

1H-Imidazole-1-ethanol, 2-nitro-alpha-((2,2,2-trifluoro-1-(trifluoromethyl)ethoxy)methyl)-

C9H9F6N3O4 (337.04972260000005)


   

Ezutromid

5-(Ethanesulphonyl)-2-(naphthalen-2-yl)-1,3-benzoxazole

C19H15NO3S (337.07726)


C78281 - Agent Affecting Musculoskeletal System

   

Fenquizone

7-chloro-4-oxo-2-phenyl-1,2,3,4-tetrahydroquinazoline-6-sulfonamide

C14H12ClN3O3S (337.0287872)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

Glutathione peroxide

14-amino-9-(sulfanylmethyl)-1,2,3,4-tetraoxa-7,10-diazacyclopentadecane-5,8,11,15-tetrone

C10H15N3O8S (337.05798300000004)


   

Sudoxicam

4-hydroxy-2-methyl-1,1-dioxo-N-(1,3-thiazol-2-yl)-2H-1lambda6,2-benzothiazine-3-carboxamide

C13H11N3O4S2 (337.0190966)


   

4-(2,5-Dihydroxypyrrol-1-yl)-N-(1,3-thiazol-2-yl)benzenesulfonamide

4-(2,5-Dihydroxy-1H-pyrrol-1-yl)-N-(1,3-thiazol-2-yl)benzene-1-sulphonamide

C13H11N3O4S2 (337.0190966)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

O1-(2-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

O1-(2-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.079763)


   

11-hydroxy-1,2,10-trimethoxy-dibenzo[de,g]quinolin-7-one|Glaunin|Glaunine

11-hydroxy-1,2,10-trimethoxy-dibenzo[de,g]quinolin-7-one|Glaunin|Glaunine

C19H15NO5 (337.09501800000004)


   

O1-(4-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

O1-(4-Hydroxy-[6]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[6]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.079763)


   

(+)-debromodiscorhabdin A|discorhabdin A trifluoroacetic acid salt

(+)-debromodiscorhabdin A|discorhabdin A trifluoroacetic acid salt

C18H15N3O2S (337.088493)


   

O1-(4-Hydroxy-[3]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[3]quinolyl)-beta-D-glucopyranuronic acid

O1-(4-Hydroxy-[3]chinolyl)-beta-D-glucopyranuronsaeure|O1-(4-hydroxy-[3]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.079763)


   
   
   

2-methyl-5-oxo-4-(2-trifluoromethyl-phenyl)-5,7-dihydro-furo[3,4-b]pyridine-3-carboxylic acid

2-methyl-5-oxo-4-(2-trifluoromethyl-phenyl)-5,7-dihydro-furo[3,4-b]pyridine-3-carboxylic acid

C16H10F3NO4 (337.05618960000004)


   
   
   
   

O1-(2-Hydroxy-[4]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[4]quinolyl)-beta-D-glucopyranuronic acid

O1-(2-Hydroxy-[4]chinolyl)-beta-D-glucopyranuronsaeure|O1-(2-hydroxy-[4]quinolyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.079763)


   
   
   

4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid

4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid

C14H11NO5S2 (337.0078636)


   
   
   
   
   

Pepcid

famotidine

C8H15N7O2S3 (337.044933)


CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2002; ORIGINAL_PRECURSOR_SCAN_NO 2000 A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1942; ORIGINAL_PRECURSOR_SCAN_NO 1939 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1950; ORIGINAL_PRECURSOR_SCAN_NO 1949 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1959; ORIGINAL_PRECURSOR_SCAN_NO 1957 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 1977; ORIGINAL_PRECURSOR_SCAN_NO 1975 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2003; ORIGINAL_PRECURSOR_SCAN_NO 2000 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4186; ORIGINAL_PRECURSOR_SCAN_NO 4184 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4210; ORIGINAL_PRECURSOR_SCAN_NO 4209 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4236; ORIGINAL_PRECURSOR_SCAN_NO 4235 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4229; ORIGINAL_PRECURSOR_SCAN_NO 4227 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4226; ORIGINAL_PRECURSOR_SCAN_NO 4225 CONFIDENCE standard compound; INTERNAL_ID 1121; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4191; ORIGINAL_PRECURSOR_SCAN_NO 4189 Famotidine (MK-208) is a competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.

   
   
   
   
   
   
   
   
   
   
   
   
   

2,8-Dihydroxyquinoline-b-D-glucuronide

2,8-Dihydroxyquinoline-beta-delta-glucuronide

C15H15NO8 (337.079763)


   

2-Oxoclopidogrel

methyl (2S)-2-(2-chlorophenyl)-2-{2-oxo-2H,4H,5H,6H,7H,7aH-thieno[3,2-c]pyridin-5-yl}acetate

C16H16ClNO3S (337.05393760000004)


Clopidogrel thiolactone is an important intermediate in the metabolism of clopidogrel (HY-15283). Clopidogrel thiolactone has antiplatelet aggregatione effects. Clopidogrel is a P2Y12 receptor inhibitor that exerts antiplatelet effects[1][2].

   

gamma-Glutamylcysteinylserine

2-amino-4-({1-[(1-carboxy-2-hydroxyethyl)carbamoyl]-2-sulfanylethyl}carbamoyl)butanoic acid

C11H19N3O7S (337.0943664)


   

HTS 01037

HTS 01037

C14H11NO5S2 (337.0078636)


HTS01037 is an inhibitor of fatty acid binding; and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 with a Ki of 0.67 μM.

   

1,1-DIOXOBENZO[B]THIOPHEN-2-YLMETHYL N-SUCCIMIDYL CARBONATE

1,1-DIOXOBENZO[B]THIOPHEN-2-YLMETHYL N-SUCCIMIDYL CARBONATE

C14H11NO7S (337.0256216)


   

N-(6-Aminohexyl)-2-nitrobenzenesulfonamide Hydrochloride

N-(6-Aminohexyl)-2-nitrobenzenesulfonamide Hydrochloride

C12H20ClN3O4S (337.08629900000005)


   
   

4-(Bromomethyl)-N,N-diphenylaniline

4-(Bromomethyl)-N,N-diphenylaniline

C19H16BrN (337.0466036)


   

3-FLUORO-2-IODOPHENYL N,N-DIETHYLCARBAMATE

3-FLUORO-2-IODOPHENYL N,N-DIETHYLCARBAMATE

C11H13FINO2 (336.997504)


   

N-(4-acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide

N-(4-acetylphenyl)-2-(2,4-dichlorophenoxy)acetamide

C16H13Cl2NO3 (337.02724480000006)


   

ethyl 2-[(2-chloroacetyl)amino]-4-(4-methylphenyl)thiophene-3-carboxylate

ethyl 2-[(2-chloroacetyl)amino]-4-(4-methylphenyl)thiophene-3-carboxylate

C16H16ClNO3S (337.05393760000004)


   

2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide

2-cyano-2-[2,3-dihydro-3-(tetrahydro-2,4,6-trioxo-5(2H)-pyrimidinylidene)-1H-isoindol-1-ylidene]-N-methylacetamide

C16H11N5O4 (337.0811006)


   

1-[(3,4-dichlorophenyl)methylamino]cyclohexane-1-carboxylic acid

1-[(3,4-dichlorophenyl)methylamino]cyclohexane-1-carboxylic acid

C14H18Cl3NO2 (337.0403058)


   

(Ferrocenylmethyl)trimethylammonium Bromide

(Ferrocenylmethyl)trimethylammonium Bromide

C14H20BrFeN (337.01284100000004)


   

Methyl 1-(5-bromopyridin-2-yl)-5-(tert-butyl)-1H-pyrazole-4-carboxylate

Methyl 1-(5-bromopyridin-2-yl)-5-(tert-butyl)-1H-pyrazole-4-carboxylate

C14H16BrN3O2 (337.0425816)


   

1-[(2,4-dichlorophenyl)methylamino]cyclohexane-1-carboxylic acid

1-[(2,4-dichlorophenyl)methylamino]cyclohexane-1-carboxylic acid

C14H18Cl3NO2 (337.0403058)


   
   

5-Hydroxymethyl-2’-deoxycytidine

5-Hydroxymethyl-2’-deoxycytidine

C10H16N3O8P (337.0674986)


   

tert-Butyl (2-fluoro-4-iodophenyl)carbamate

tert-Butyl (2-fluoro-4-iodophenyl)carbamate

C11H13FINO2 (336.997504)


   

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

tert-butyl 1-(4-bromophenyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate

C16H20BrNO2 (337.06773200000003)


   

tris(cyclopentadienyl)neodymium

tris(cyclopentadienyl)neodymium

C15H15Nd (337.0251)


   

Benzyl 2,4-dichloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

Benzyl 2,4-dichloro-7,8-dihydropyrido[4,3-d]pyrimidine-6(5H)-carboxylate

C15H13Cl2N3O2 (337.0384778)


   

7-Quinolinecarboxaldehyde, 2-[2-(3,4-dihydroxy-5-methoxyphenyl)ethenyl]-8-hydroxy-

7-Quinolinecarboxaldehyde, 2-[2-(3,4-dihydroxy-5-methoxyphenyl)ethenyl]-8-hydroxy-

C19H15NO5 (337.09501800000004)


   
   

1-(4-CHLORO-3-NITROPHENYL)-2-PHENYLETHANONE

1-(4-CHLORO-3-NITROPHENYL)-2-PHENYLETHANONE

C17H11ClF3NO (337.0481222)


   

2-BENZOTHIAZOLYL-3-(4-CARBOXY-2-METHOXYPHENYL)-5-[4-(2-SULFOETHYLCARBAMOYL)PHENYL]-2H-TETRAZOLIUM

2-BENZOTHIAZOLYL-3-(4-CARBOXY-2-METHOXYPHENYL)-5-[4-(2-SULFOETHYLCARBAMOYL)PHENYL]-2H-TETRAZOLIUM

C10H16N3O6PS (337.0497406)


   
   
   
   

(Cyanomethyl)(triphenyl)phosphonium chloride

(Cyanomethyl)(triphenyl)phosphonium chloride

C20H17ClNP (337.07870820000005)


   

(2R)-4-Bromo-2-[[(tert-butoxy)carbonyl]amino]butanoic acid tert-butyl ester

(2R)-4-Bromo-2-[[(tert-butoxy)carbonyl]amino]butanoic acid tert-butyl ester

C13H24BrNO4 (337.08886040000004)


   

3-[[1-(3,4-dichlorophenyl)ethylideneamino]oxymethyl]benzoic acid

3-[[1-(3,4-dichlorophenyl)ethylideneamino]oxymethyl]benzoic acid

C16H13Cl2NO3 (337.02724480000006)


   

4-nitrophenyl-beta-d-glucuronic acid, sodium salt

4-nitrophenyl-beta-d-glucuronic acid, sodium salt

C12H12NNaO9 (337.0409742)


   
   

3-(4-FLUORO-PHENYL)-3-(TOLUENE-4-SULFONYLAMINO)-PROPIONIC ACID

3-(4-FLUORO-PHENYL)-3-(TOLUENE-4-SULFONYLAMINO)-PROPIONIC ACID

C16H16FNO4S (337.0784028)


   

tert-Butyl (4-fluoro-2-iodophenyl)carbamate

tert-Butyl (4-fluoro-2-iodophenyl)carbamate

C11H13FINO2 (336.997504)


   
   

5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine

5-Bromo-N-(4-methoxybenzyl)-3-nitropyridin-2-amine

C13H12BrN3O3 (337.0061982)


   

Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate

Benzyl 2,4-dichloro-5,6-dihydropyrido[3,4-d]pyrimidine-7(8H)-carboxylate

C15H13Cl2N3O2 (337.0384778)


   
   

Intrazole

(4-chlorophenyl)-[3-(2H-tetrazol-5-ylmethyl)indol-1-yl]methanone

C17H12ClN5O (337.0730332)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

1-[(3-Bromo-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl]-4-piperidinecar boxylic acid

1-[(3-Bromo-1H-pyrrolo[2,3-b]pyridin-2-yl)methyl]-4-piperidinecar boxylic acid

C14H16BrN3O2 (337.0425816)


   
   
   

N-[2,3-Dihydro-2-(4-methoxybenzoyl)-1,3-dioxo-1H-inden-4-yl]acetamide

N-[2,3-Dihydro-2-(4-methoxybenzoyl)-1,3-dioxo-1H-inden-4-yl]acetamide

C19H15NO5 (337.09501800000004)


   

UNC669

(5-Bromopyridin-3-yl)(4-(pyrrolidin-1-yl)piperidin-1-yl)methanone

C15H20BrN3O (337.07896500000004)


   
   
   

ethyl 2-(broMoMethyl)-8-cyano-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

ethyl 2-(broMoMethyl)-8-cyano-7-MethoxyiMidazo[1,2-a]pyridine-3-carboxylate

C13H12BrN3O3 (337.0061982)


   

ETHYL 3-(4-CHLOROANILINE)-2-(2,5-DIOXOTETRAHYDROFURAN-3-YL)BUT-2-ENOATE

ETHYL 3-(4-CHLOROANILINE)-2-(2,5-DIOXOTETRAHYDROFURAN-3-YL)BUT-2-ENOATE

C16H16ClNO5 (337.0716956)


   

sodium,2-[N-(ethoxymethyl)-2-ethyl-6-methylanilino]-2-oxoethanesulfonate

sodium,2-[N-(ethoxymethyl)-2-ethyl-6-methylanilino]-2-oxoethanesulfonate

C14H20NNaO5S (337.09598300000005)


   

N-( 4-Bromophenyl)-N-(4-methylphenyl)aniline

N-( 4-Bromophenyl)-N-(4-methylphenyl)aniline

C19H16BrN (337.0466036)


   

1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)-2,2,2-trifluoroethanone

1-(4-(5-Bromopyridin-2-yl)piperazin-1-yl)-2,2,2-trifluoroethanone

C11H11BrF3N3O (337.0037532)


   

4-[(4-CHLORO-2,5-DIMETHYLPHENYL)THIO]-3-NITROBENZOIC ACID

4-[(4-CHLORO-2,5-DIMETHYLPHENYL)THIO]-3-NITROBENZOIC ACID

C15H12ClNO4S (337.0175542)


   

(dimethyl)[3-thieno[2,3-c][2]benzothiepin-4(9H)-ylidenepropyl]ammonium chloride

(dimethyl)[3-thieno[2,3-c][2]benzothiepin-4(9H)-ylidenepropyl]ammonium chloride

C17H20ClNS2 (337.07256300000006)


   

4-(4-ethoxyanilino)-3-nitrobenzenesulfonamide

4-(4-ethoxyanilino)-3-nitrobenzenesulfonamide

C14H15N3O5S (337.073238)


   

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

2-[3-(5-Mercapto-[1,3,4]thiadiazol-2-YL)-ureido]-N-methyl-3-phenyl-propionamide

C13H15N5O2S2 (337.066713)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D061965 - Matrix Metalloproteinase Inhibitors

   

Ethyl 3-[(E)-2-Amino-1-Cyanoethenyl]-6,7-Dichloro-1-Methyl-1h-Indole-2-Carboxylate

Ethyl 3-[(E)-2-Amino-1-Cyanoethenyl]-6,7-Dichloro-1-Methyl-1h-Indole-2-Carboxylate

C15H13Cl2N3O2 (337.0384778)


   

5-Methylcytidine 5-monophosphate

5-Methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

9-(5,5-Difluoro-5-phosphonopentyl)guanine

9-(5,5-Difluoro-5-phosphonopentyl)guanine

C10H14F2N5O4P (337.07514380000003)


   

N-[1-(4-Bromophenyl)ethyl]-5-fluoro salicylamide

N-[1-(4-Bromophenyl)ethyl]-5-fluoro salicylamide

C15H13BrFNO2 (337.011363)


   

Sudoxicam

Sudoxicam

C13H11N3O4S2 (337.0190966)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

Clodanolene

Clodanolene

C14H9Cl2N3O3 (337.00209440000003)


C78281 - Agent Affecting Musculoskeletal System > C29696 - Muscle Relaxant

   

2-(1-Piperidinyl)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrile

2-(1-Piperidinyl)-6-thiophen-2-yl-4-(trifluoromethyl)-3-pyridinecarbonitrile

C16H14F3N3S (337.08604800000006)


   

2-O-methylcytidine 5-monophosphate

2-O-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

3-[(5Z)-5-[(4-ethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

3-[(5Z)-5-[(4-ethoxyphenyl)methylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid

C15H15NO4S2 (337.044247)


   

3-[(4-Fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine

3-[(4-Fluorophenyl)methylthio]-6-pyridin-4-yl-[1,2,4]triazolo[4,3-b]pyridazine

C17H12FN5S (337.07974040000005)


   

Phenacyl 2-quinolin-8-ylsulfanylacetate

Phenacyl 2-quinolin-8-ylsulfanylacetate

C19H15NO3S (337.07726)


   

3-[(2-Chloro-6-fluorophenyl)methylthio]-4-ethyl-5-(2-furanyl)-1,2,4-triazole

3-[(2-Chloro-6-fluorophenyl)methylthio]-4-ethyl-5-(2-furanyl)-1,2,4-triazole

C15H13ClFN3OS (337.04518500000006)


   

N-[4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]acetamide

N-[4-(1-methylsulfonyl-2,3-dihydroindol-5-yl)-2-thiazolyl]acetamide

C14H15N3O3S2 (337.05548)


   

5-[(6-Nitro-1,3-benzodioxol-5-yl)hydrazinylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

5-[(6-Nitro-1,3-benzodioxol-5-yl)hydrazinylidene]-2-sulfanylidene-1,3-diazinane-4,6-dione

C11H7N5O6S (337.01170420000005)


   

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

2-[[5-(2-Chlorophenyl)-1,3,4-oxadiazol-2-yl]thio]-1-(1-piperidinyl)ethanone

C15H16ClN3O2S (337.0651706)


   

H-DL-gGlu-DL-Cys(MeOH)-Gly-OH

H-DL-gGlu-DL-Cys(MeOH)-Gly-OH

C11H19N3O7S (337.0943664)


D013501 - Surface-Active Agents > D011092 - Polyethylene Glycols D001697 - Biomedical and Dental Materials

   

3-Ethyl-6-{[(4-Fluorophenyl)sulfonyl]amino}-2-Methylbenzoic Acid

3-Ethyl-6-{[(4-Fluorophenyl)sulfonyl]amino}-2-Methylbenzoic Acid

C16H16FNO4S (337.0784028)


   
   

[(2R,3S,4R,5R)-5-(4-carbamoyl-5-oxidoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

[(2R,3S,4R,5R)-5-(4-carbamoyl-5-oxidoimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen phosphate

C9H12N3O9P-2 (337.0311152)


   

fenquizone

fenquizone

C14H12ClN3O3S (337.0287872)


C - Cardiovascular system > C03 - Diuretics > C03B - Low-ceiling diuretics, excl. thiazides > C03BA - Sulfonamides, plain C78275 - Agent Affecting Blood or Body Fluid > C448 - Diuretic > C49185 - Thiazide Diuretic D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics

   

5-Hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9,11,13(17),14-octaen-8-one

5-Hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.02,7.013,17]heptadeca-1(16),2(7),3,5,9,11,13(17),14-octaen-8-one

C19H15NO5 (337.09501800000004)


   
   

5-Hydroxycytidine monophosphate

5-Hydroxycytidine monophosphate

C9H12N3O9P-2 (337.0311152)


   

trans-5-O-(4-Coumaroyl)-D-quinate

trans-5-O-(4-Coumaroyl)-D-quinate

C16H17O8- (337.09233820000003)


The conjugate base of trans-5-O-(4-coumaroyl)-D-quinic acid.

   

4-carbamoyl-1-(5-O-phosphonato-beta-D-ribofuranosyl)-1H-imidazol-3-ium-5-olate

4-carbamoyl-1-(5-O-phosphonato-beta-D-ribofuranosyl)-1H-imidazol-3-ium-5-olate

C9H12N3O9P-2 (337.0311152)


D000890 - Anti-Infective Agents > D000977 - Antiparasitic Agents > D000981 - Antiprotozoal Agents D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D007155 - Immunologic Factors > D007166 - Immunosuppressive Agents D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D000970 - Antineoplastic Agents D018501 - Antirheumatic Agents D004791 - Enzyme Inhibitors

   
   
   
   
   
   

2,4,7,9-Tetrahydroxy-6,11-dioxotetracen-5-olate

2,4,7,9-Tetrahydroxy-6,11-dioxotetracen-5-olate

C18H9O7- (337.0348264)


   

(L-cysteinato-kappaS~3~)(methyl)mercury

(L-cysteinato-kappaS~3~)(methyl)mercury

C4H9HgNO2S (337.00602940000005)


   
   
   

Oxythiamine chloride hydrochloride

Oxythiamine chloride hydrochloride

C12H17Cl2N3O2S (337.04184820000006)


D009676 - Noxae > D000963 - Antimetabolites

   

(E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid

(E)-4-[(2-methoxycarbonyl-5-thiophen-2-ylthiophen-3-yl)amino]-4-oxobut-2-enoic acid

C14H11NO5S2 (337.0078636)


HTS01037 is an inhibitor of fatty acid binding; and a competitive antagonist of protein-protein interactions mediated by AFABP/aP2 with a Ki of 0.67 μM.

   

Disufenton

Disufenton

C11H15NO7S2 (337.02899199999996)


C26170 - Protective Agent > C1509 - Neuroprotective Agent D020011 - Protective Agents > D000975 - Antioxidants D002317 - Cardiovascular Agents

   

N-[(3-nitrophenyl)methylideneamino]-4-oxo-1H-quinazoline-2-carboxamide

N-[(3-nitrophenyl)methylideneamino]-4-oxo-1H-quinazoline-2-carboxamide

C16H11N5O4 (337.0811006)


   

5-amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-)

5-amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-)

C9H12N3O9P-2 (337.0311152)


COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

2-methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-thieno[2,3-e]thiazine-3-carboxamide

2-methyl-1,1,4-trioxo-N-(2-pyridinyl)-3H-thieno[2,3-e]thiazine-3-carboxamide

C13H11N3O4S2 (337.0190966)


   

N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide

N-methyl-2-[[4-methyl-5-[(4-nitrophenoxy)methyl]-1,2,4-triazol-3-yl]thio]acetamide

C13H15N5O4S (337.08447100000006)


   

(Quinolin-2-ylsulfanyl)-acetic acid (4-hydroxy-benzylidene)-hydrazide

(Quinolin-2-ylsulfanyl)-acetic acid (4-hydroxy-benzylidene)-hydrazide

C18H15N3O2S (337.088493)


   

N(3)-methylcytidine 5-monophosphate

N(3)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

N-[2-(2,6-dichloroanilino)-2-oxoethyl]-N-methyl-4-pyridinecarboxamide

N-[2-(2,6-dichloroanilino)-2-oxoethyl]-N-methyl-4-pyridinecarboxamide

C15H13Cl2N3O2 (337.0384778)


   

N-(3-cyano-5-methyl-4-phenyl-2-thiophenyl)-3,5-dimethyl-4-isoxazolecarboxamide

N-(3-cyano-5-methyl-4-phenyl-2-thiophenyl)-3,5-dimethyl-4-isoxazolecarboxamide

C18H15N3O2S (337.088493)


   

N-(2-adamantyl)-4-bromo-1-methyl-3-pyrazolecarboxamide

N-(2-adamantyl)-4-bromo-1-methyl-3-pyrazolecarboxamide

C15H20BrN3O (337.07896500000004)


   

N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

N-[2-(methylthio)phenyl]-2,3-dihydro-1,4-benzodioxin-6-sulfonamide

C15H15NO4S2 (337.044247)


   

5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid methyl ester

5-[2-[(4-chlorophenyl)thio]-1-oxoethyl]-2,4-dimethyl-1H-pyrrole-3-carboxylic acid methyl ester

C16H16ClNO3S (337.05393760000004)


   

4-methoxy-N-[(2-thioxo-1,2-dihydro-3-quinolinyl)methylene]benzohydrazide

4-methoxy-N-[(2-thioxo-1,2-dihydro-3-quinolinyl)methylene]benzohydrazide

C18H15N3O2S (337.088493)


   

3-[1-(4-Chlorophenyl)-5-tetrazolyl]-1-methyl-4-quinolinone

3-[1-(4-Chlorophenyl)-5-tetrazolyl]-1-methyl-4-quinolinone

C17H12ClN5O (337.0730332)


   

2-[[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(1,3,4-thiadiazol-2-yl)acetamide

2-[[5-(3-fluorophenyl)-1,3,4-oxadiazol-2-yl]thio]-N-(1,3,4-thiadiazol-2-yl)acetamide

C12H8FN5O2S2 (337.010344)


   

2-methyl-6-[(5-phenylthiophene-2-carbonyl)amino]benzoic Acid

2-methyl-6-[(5-phenylthiophene-2-carbonyl)amino]benzoic Acid

C19H15NO3S (337.07726)


   
   

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

3-bromo-2-heptyl-1-hydroxy-4(1H)-quinolinone

C16H20BrNO2 (337.06773200000003)


   
   

N(4)-methylcytidine 5-monophosphate

N(4)-methylcytidine 5-monophosphate

C10H16N3O8P (337.0674986)


   

N-[2-(uran-2-ylmethylsulanyl)ethyl]-2-(3-methoxyphenyl)sulanylacetamide

N-[2-(uran-2-ylmethylsulanyl)ethyl]-2-(3-methoxyphenyl)sulanylacetamide

C16H19NO3S2 (337.08063039999996)


   
   
   
   
   
   
   
   
   
   
   
   

1-Hydroxy-1-oxo-3-methyl-3-butylbenziodoxazole

1-Hydroxy-1-oxo-3-methyl-3-butylbenziodoxazole

C11H16INO3 (337.0174896)


   

1-O-(1H-indol-3-ylcarbonyl)-beta-D-glucopyranuronic acid

1-O-(1H-indol-3-ylcarbonyl)-beta-D-glucopyranuronic acid

C15H15NO8 (337.079763)


   

(E)-4-(3-chlorophenyl)-2-oxo-3-quinolin-2-ylbut-3-enoic acid

(E)-4-(3-chlorophenyl)-2-oxo-3-quinolin-2-ylbut-3-enoic acid

C19H12ClNO3 (337.05056720000005)


   

[(4S,5R)-3-(4-amino-2-oxopyrimidin-1-yl)-2-fluoro-4,5-dihydroxycyclopenten-1-yl]methyl dihydrogen phosphate

[(4S,5R)-3-(4-amino-2-oxopyrimidin-1-yl)-2-fluoro-4,5-dihydroxycyclopenten-1-yl]methyl dihydrogen phosphate

C10H13FN3O7P (337.04751300000004)


   

5-Hydroxymethyldeoxycytidylic acid

5-Hydroxymethyldeoxycytidylic acid

C10H16N3O8P (337.0674986)


   

S-(Hydroxymethyl)glutathione

S-(Hydroxymethyl)glutathione

C11H19N3O7S (337.0943664)


An S-substituted glutathione that is glutathione in which the mercapto hydrogen has been replaced by a hydroxymethyl group.

   

2,8-Dihydroxyquinoline-beta-D-glucuronide

2,8-Dihydroxyquinoline-beta-D-glucuronide

C15H15NO8 (337.079763)


   

versicolorin A(1-)

versicolorin A(1-)

C18H9O7 (337.0348264)


A phenolate anion obtained by deprotonation of the 8-hydroxy group of versicolorin A. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).

   

3-Indole carboxylic acid glucuronide

3-Indole carboxylic acid glucuronide

C15H15NO8 (337.079763)


An O-acyl carbohydrate obtained by formal condensation of the carboxy group of indole-3-carboxylic acid with the anomeric hydroxy group of beta-D-glucuronic acid.

   

5-amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-)

5-amino-1-(5-phosphonato-D-ribosyl)imidazolium-4-carboxylate(2-)

C9H12N3O9P (337.0311152)


An organophosphate oxoanion that is the major structure at pH 7.3 of 5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxylic acid.

   

COR659

COR659

C16H16ClNO3S (337.05393760000004)


COR659 is a potent and effective GABAB positive allosteric modulator (PAM). COR659 suppresses alcohol and chocolate self-administration in rats[1].

   

PSB-12062

PSB-12062

C19H15NO3S (337.07726)


PSB-12062 is a potent and selective P2X4 antagonist with an IC50 of 1.38 μM for human P2X4.

   

TRC160334

TRC160334

C14H15N3O5S (337.073238)


TRC160334 is a hypoxia-inducible factor (HIF) hydroxylase inhibitor. TRC160334 can be used for the research of ischemia/reperfusion injury[1].

   

11-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-12-one

11-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-12-one

C19H15NO5 (337.09501800000004)


   

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylbutyl)amine

({5'-bromo-4-methoxy-1h,1'h-[2,2'-bipyrrol]-5-yl}methylidene)(2-methylbutyl)amine

C15H20BrN3O (337.07896500000004)


   

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),8,12,14(19),16-hexaene-15,18-dione

C19H15NO5 (337.09501800000004)


   

5-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2,4,7,9(17),10,12,14-octaen-6-one

5-hydroxy-14,15,16-trimethoxy-10-azatetracyclo[7.7.1.0²,⁸.0¹³,¹⁷]heptadeca-1(16),2,4,7,9(17),10,12,14-octaen-6-one

C19H15NO5 (337.09501800000004)


   

4,5,17-trimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

4,5,17-trimethoxy-2-oxa-11-azatetracyclo[8.7.1.0³,⁸.0¹⁴,¹⁸]octadeca-1(17),3,5,7,10(18),11,13,15-octaen-9-one

C19H15NO5 (337.09501800000004)